Adeptus Health (ADPT) : Zacks Investment Research ranks Adeptus Health (ADPT) as 5, which is a Strong Sell recommendation. 4 research analysts consider that the stocks fundamentals point to a bright future, hence they rate the stock as a Strong Buy. A total of 1 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 5 research analysts is 1.4, which indicates as a Strong Buy.
Adeptus Health (ADPT) : Currently there are 5 street experts covering Adeptus Health (ADPT) stock. The most bullish and bearish price target for the stock is $103 and $67 respectively for the short term. The average price target of all the analysts comes to $88.6. The estimated standard deviation from the target is $14.47.
For the current week, the company shares have a recommendation consensus of Buy. Adeptus Health (NYSE:ADPT): The stock opened at $43.64 on Thursday but the bulls could not build on the opening and the stock topped out at $44.16 for the day. The stock traded down to $42.94 during the day, due to lack of any buying support eventually closed down at $43.02 with a loss of -1.35% for the day. The stock had closed at $43.61 on the previous day. The total traded volume was 273,275 shares.
Adeptus Health Inc. is a holding company. The Company owns and operates First Choice Emergency Rooms, a network of independent freestanding emergency rooms in the United States. The Company provides emergency care through its freestanding emergency rooms. The Company provides patients with access to Board-certified physicians and emergency trained registered nurses and treatments on?site. The Companys facilities are equipped with radiology suite, including computerized tomography (CT) scanners, digital x-ray and ultrasound, as well as onsite laboratories. As of December 31, 2014, the Company had 55 facilities. The Companys facilities are located in the Houston, Dallas/Fort Worth, San Antonio and Austin, Texas markets; Colorado Springs and Denver, Colorado, and Phoenix, Arizona.